Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 06:35PM GMT
Release Date Price: €68 (+1.49%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

All right. Good afternoon, everybody. I'm Luke Sergott. I cover life sciences tools and diagnostics here at Barclays. It's my pleasure to have with me Jim Hippel from CFO of Bio-Techne. It's been a long time. We're just commenting it's about 3 years for you. I'm glad to have you back.

Questions & Answers

Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

To kick it off, let's start off just like real high-level thoughts of what you saw coming out of your quarter. The underlying market demand going into your guidance and -- we can start there and then dig in further.

James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO

Sure. I think I'll start on a positive note, which is that our underlying demand and the health of our end markets, we believe, are still very strong. And despite this print, what makes me say that is in the last few years of COVID noise, you got to dig a little

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot